AA
MRK icon

Argent Advisors’s Merck MRK Stock Holding History

Argent Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Sell
24,547
-211
-0.9% -$24.7K 0.79% 32
2026
Q1 		$2.98M Sell
24,758
-62
-0.2% -$7.16K 0.81% 34
2025
Q4 		$2.61M Buy
24,820
+450
+2% +$42.2K 0.73% 36
2025
Q3 		$2.05M Buy
24,370
+1,387
+6% +$114K 0.6% 45
2025
Q2 		$1.82M Buy
22,983
+2,380
+12% +$189K 0.56% 46
2025
Q1 		$1.85M Buy
20,603
+4,029
+24% +$376K 0.62% 43
2024
Q4 		$1.65M Buy
16,574
+361
+2% +$37.2K 0.61% 45
2024
Q3 		$1.84M Sell
16,213
-400
-2% -$47.5K 0.68% 38
2024
Q2 		$2.06M Buy
16,613
+25
+0.2% +$3.22K 0.82% 29
2024
Q1 		$2.19M Sell
16,588
-100
-0.6% -$12.3K 0.87% 27
2023
Q4 		$1.82M Sell
16,688
-169
-1% -$17.5K 0.8% 30
2023
Q3 		$1.74M Sell
16,857
-64
-0.4% -$6.9K 0.79% 29
2023
Q2 		$1.95M Sell
16,921
-231
-1% -$26.2K 0.9% 22
2023
Q1 		$1.82M Sell
17,152
-1,019
-6% -$110K 0.87% 24
2022
Q4 		$2.02M Sell
18,171
-406
-2% -$41.5K 1.04% 20
2022
Q3 		$1.6M Sell
18,577
-222
-1% -$19.8K 0.93% 24
2022
Q2 		$1.71M Sell
18,799
-43
-0.2% -$3.81K 0.96% 23
2022
Q1 		$1.55M Buy
18,842
+1,324
+8% +$104K 0.83% 35
2021
Q4 		$1.34M Buy
17,518
+156
+0.9% +$12.4K 0.72% 36
2021
Q3 		$1.3M Buy
17,362
+2,073
+14% +$158K 0.75% 33
2021
Q2 		$1.19M Buy
15,289
+356
+2% +$26.5K 0.72% 35
2021
Q1 		$1.1M Buy
14,933
+790
+6% +$58.3K 0.71% 34
2020
Q4 		$1.1M Buy
14,143
+1,493
+12% +$114K 0.68% 40
2020
Q3 		$1M Buy
12,650
+377
+3% +$29.5K 0.69% 39
2020
Q2 		$905K Buy
12,273
+1,033
+9% +$77.8K 0.69% 38
2020
Q1 		$825K Buy
11,240
+57
+0.5% +$4.48K 0.83% 29
2019
Q4 		$975K Buy
+11,183
New +$919K 0.73% 30

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Argent Advisors's MRK Position: Q2 2026 in Review

Argent Advisors reduced its Merck (MRK) stake by 0.85% in Q2 2026, selling an estimated $24.7K and leaving 24,547 shares worth $3.15M. The position accounts for 0.79% of the portfolio, ranked #32.

Argent Advisors first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Argent Advisors held 24,547 shares of Merck worth $3.15M as of Q2 2026.
  • Argent Advisors sold 211 Merck shares in Q2 2026, an estimated $24.7K.
  • Merck made up 0.79% of Argent Advisors's portfolio in Q2 2026, its #32 holding.
  • Argent Advisors first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Argent Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.